MPG.eBooks - Search Results - "Sodium-glucose Transporter 2 Inhibitors"

Search alternatives:
transporter 2 » transporter _
2 inhibitors » _ inhibitors

Cover Image

1

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

2

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

3

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

4

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

6

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

7

CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”